Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Nguyen

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2021
"One-Two Punch": Synergistic ß-Lactam Combinations for Mycobacterium abscessus and Target Redundancy in the Inhibition of Peptidoglycan Synthesis EnzymesDavid C Nguyen, Khalid M Dousa, Sebastian G Kurz, et al.
ACS Infectious Diseases|April 15, 2024
Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of <i>Mycobacterium tuberculosis</i>Mary Nantongo, David C Nguyen, Christopher R Bethel, et al.
The Pediatric Infectious Disease Journal|September 1, 2018
A Multi-Centered Case-Case-Control Study of Factors Associated With Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Infections in Children and Young AdultsLatania K Logan, David C Nguyen, Felicia A Scaggs Huang, et al.
Mbio|May 14, 2024
Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against <i>Mycobacterium abscessus</i>Khalid M Dousa, Eunjeong Shin, Sebastian G Kurz, et al.
Mbio|July 10, 2025
Exploring β-lactam interactions with DacB1: unraveling optimal therapies for combating drug-resistant <i>Mycobacterium tuberculosis</i>Mary Nantongo, David C Nguyen, Eunjeong Shin, et al.
Infectious Diseases and Therapy|February 18, 2019
The Clinical and Molecular Epidemiology of CTX-M-9 Group Producing Enterobacteriaceae Infections in ChildrenLatania K Logan, Rachel L Medernach, T Nicholas Domitrovic, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2025
Novel C5α-substituted carbapenems enhance <i>Mycobacterium abscessus</i> killing via selective target binding and reduced hydrolysis by Bla<sub>Mab</sub>Eunjeong Shin, Magdalena A Taracila, Pojun Quan, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2024
Durlobactam in combination with β-lactams to combat <i>Mycobacterium abscessus</i>Eunjeong Shin, Khalid M Dousa, Magdalena A Taracila, et al.
Mbio|January 25, 2022
Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam ActionKhalid M Dousa, David C Nguyen, Sebastian G Kurz, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2021
"One-Two Punch": Synergistic ß-Lactam Combinations for Mycobacterium abscessus and Target Redundancy in the Inhibition of Peptidoglycan Synthesis EnzymesDavid C Nguyen, Khalid M Dousa, Sebastian G Kurz, et al.
ACS Infectious Diseases|April 15, 2024
Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of <i>Mycobacterium tuberculosis</i>Mary Nantongo, David C Nguyen, Christopher R Bethel, et al.
The Pediatric Infectious Disease Journal|September 1, 2018
A Multi-Centered Case-Case-Control Study of Factors Associated With Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Infections in Children and Young AdultsLatania K Logan, David C Nguyen, Felicia A Scaggs Huang, et al.
Mbio|May 14, 2024
Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against <i>Mycobacterium abscessus</i>Khalid M Dousa, Eunjeong Shin, Sebastian G Kurz, et al.
Mbio|July 10, 2025
Exploring β-lactam interactions with DacB1: unraveling optimal therapies for combating drug-resistant <i>Mycobacterium tuberculosis</i>Mary Nantongo, David C Nguyen, Eunjeong Shin, et al.
Infectious Diseases and Therapy|February 18, 2019
The Clinical and Molecular Epidemiology of CTX-M-9 Group Producing Enterobacteriaceae Infections in ChildrenLatania K Logan, Rachel L Medernach, T Nicholas Domitrovic, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2025
Novel C5α-substituted carbapenems enhance <i>Mycobacterium abscessus</i> killing via selective target binding and reduced hydrolysis by Bla<sub>Mab</sub>Eunjeong Shin, Magdalena A Taracila, Pojun Quan, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2024
Durlobactam in combination with β-lactams to combat <i>Mycobacterium abscessus</i>Eunjeong Shin, Khalid M Dousa, Magdalena A Taracila, et al.
Mbio|January 25, 2022
Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam ActionKhalid M Dousa, David C Nguyen, Sebastian G Kurz, et al.
Pageof 2